B+
Bull case
30%
Probability
Target price
$12.50
Analysis reference price unavailable
Analysis 2026-09-12 · RankAlpha Sentiment Codex
VMD
Viemed HealthcareANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Record revenue, renewed ventilator growth, rapid PAP and resupply expansion, $15.9 million of quarterly operating cash flow, and a lower capital-expenditure outlook support a constructive growth-and-cash-conversion thesis [#SEC-8K-2026-08-03].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -15.3.
What can break
A director and chief medical officer sold 10,000 shares at $11.72 on June 25, 2026; this is a monitoring signal rather than evidence about operating performance [#SEC-FORM4-2026-06-26].
Momentum
8
Value
70
Sentiment
100
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $10.25 · Bull $12.50 · Bear $6.75Analysis 2026-09-12; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-12 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $12.50
Why
Momentum8 · Δ7d +3.3
Value70 · Δ7d -0.0
Sentiment100 · Δ7d -15.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -15.3.
Contradictions & invalidation
- • A director and chief medical officer sold 10,000 shares at $11.72 on June 25, 2026; this is a monitoring signal rather than evidence about operating performance [#SEC-FORM4-2026-06-26].
- • Home-ventilation growth depends on continued execution under CMS qualification, documentation, and utilization standards [#PR-EARNINGS-2026-08-11].
- • Adjusted EBITDA declined 4.0% year over year and full-year EBITDA guidance was reduced despite stronger revenue expectations, indicating margin or mix pressure.
Catalyst clock
2026-12-31
FY2026 guidance delivery after mixed Q2 revision
Lead driver: Sentiment · See AI snapshot
Momentum
8
9% active weight
Current posture
7d trendImproving
Δ7d
+3.3
Δ21d
-0.1
Value
70
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+1.2
Sentiment
100
62% active weight
Current posture
7d trendSoftening
Δ7d
-15.3
Δ21d
-4.1
Why this grade
Composite grade A. Momentum 7.7 / Value 69.8 / Sentiment 100.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-12. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$10.25
Analysis reference price unavailable
Analysis 2026-09-12 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$6.75
Analysis reference price unavailable
Analysis 2026-09-12 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$344.7M
Beta
1.27
Shares Out
38.09M
P/E (TTM)
21.9
P/S (TTM)
1.08
P/FCF (TTM)
51.26
Rev YoY
+23.9%
EPS YoY
-12.5%
Gross Margin
+56.9%
Op Margin
+8.5%
Net Debt
$2.45M
Current Ratio
1.13
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data